Physiotherapy Interventions in Lung Cancer Patients: A Systematic Review

Author:

Valdivia-Martínez Manuel1,Fernández-Gualda Miguel Ángel234,Gallegos-García Elena1,Postigo-Martin Paula2345ORCID,Fernández-González María1,Ortiz-Comino Lucía2345ORCID

Affiliation:

1. Faculty of Health Sciences, University of Granada, 18071 Granada, Spain

2. A02-Cuídate, Instituto de Investigación Biosanitaria ibs. GRANADA, 18012 Granada, Spain

3. Sports and Health Research Center (IMUDs), Parque Tecnológico de la Salud, 18007 Granada, Spain

4. BIO277 Group, Department of Physical Therapy, Faculty of Health Sciences, University of Granada, 18071 Granada, Spain

5. Faculty of Health Sciences Faculty (Melilla), University of Granada, 52005 Melilla, Spain

Abstract

Background: Lung cancer is a very common disease and leads to a series of sequelae such as reduced lung capacity or reduced functional capacity in patients, which are associated not only with the disease itself, but also with medical treatment. Thus, physiotherapeutic interventions are needed to improve quality of life and reduce these symptoms. Objectives: To find out the effects of physiotherapy on functional capacity, lung capacity, dyspnea, pain, and quality of life in lung cancer patients. Methods: A systematic review was carried out in five databases. Randomized clinical trials published between 2019–2023 were selected, in which the physiotherapeutic treatment was physical exercise and/or respiratory physiotherapy. Results: Nine articles were included, in which the total sample consisted of 635 lung cancer patients. When combined, respiratory physiotherapy and physical exercise improved functional capacity and lung capacity (p < 0.05). Dyspnea also improved, but less significance was shown in the included studies. Conclusions: Multimodal physiotherapy interventions may offer benefits for some lung cancer patients, but the extent and nature of these benefits may vary depending on the intervention applied. Therefore, it would be of great interest to carry out further scientific research to support this conclusion.

Publisher

MDPI AG

Reference44 articles.

1. Lung Cancer 2020: Epidemiology, Etiology, and Prevention;Bade;Clin. Chest Med.,2020

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

3. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer;Chansky;J. Thorac. Oncol.,2017

4. Menéndez, P., Sánchez-Torres, J.M., Bartolomé, A., Bravo, J.L., Caballero-Guerra, P., Calzas-Rodríguez, J., Cortés-Funes, H., Díaz-Hellín, V., Doñado-Uña, J.R., and Enguita, A.B. (2009). OncoSur Guía Clínica de Diagnóstico y Tratamiento Del Cáncer de Pulmón, Grupo de trabajo oncológico de centros hospitalarios del sur de Madrid.

5. Chemotherapy Remains a Cornerstone in the Treatment of Nonsmall Cell Lung Cancer;Pirker;Curr. Opin. Oncol.,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3